{"id":"https://openalex.org/W4415212160","doi":"https://doi.org/10.1158/1078-0432.30363063","title":"Supplementary Table S3 from FDA Approval Summary: Blinatumomab for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia in the Consolidation Phase of Multiphase Chemotherapy","display_name":"Supplementary Table S3 from FDA Approval Summary: Blinatumomab for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia in the Consolidation Phase of Multiphase Chemotherapy","alternate_titles":[],"publication_year":2025,"publication_date":"2025-10-15","ids":{"openalex":"https://openalex.org/W4415212160","doi":"https://doi.org/10.1158/1078-0432.30363063"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.30363063","doi":"https://doi.org/10.1158/1078-0432.30363063","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30363063","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S3_from_FDA_Approval_Summary_Blinatumomab_for_the_Treatment_of_B-Cell_Precursor_Acute_Lymphoblastic_Leukemia_in_the_Consolidation_Phase_of_Multiphase_Chemotherapy/30363063/1/files/58751496.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"parent_works":[],"lineage":["https://openalex.org/W4415212160"],"child_works_count":0,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S3_from_FDA_Approval_Summary_Blinatumomab_for_the_Treatment_of_B-Cell_Precursor_Acute_Lymphoblastic_Leukemia_in_the_Consolidation_Phase_of_Multiphase_Chemotherapy/30363063/1/files/58751496.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085555874","display_name":"Cara A. Rabik","orcid":"https://orcid.org/0000-0002-1076-5942","observed_orcids":["https://orcid.org/0000-0002-1076-5942"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cara A. Rabik","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1076-5942","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027946189","display_name":"Shu Wang","orcid":"https://orcid.org/0000-0001-9813-6069","observed_orcids":["https://orcid.org/0000-0001-9813-6069","https://orcid.org/0000-0002-4270-5645"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shu Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9813-6069","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5118749442","display_name":"Ritu Chadda","orcid":"https://orcid.org/0009-0006-3613-6841","observed_orcids":["https://orcid.org/0009-0006-3613-6841"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ritu Chadda","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-3613-6841","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066528744","display_name":"Donna Przepiorka","orcid":"https://orcid.org/0000-0002-4825-7775","observed_orcids":["https://orcid.org/0000-0002-4825-7775"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Donna Przepiorka","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4825-7775","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038644290","display_name":"Jonathon Joseph Vallejo","orcid":"https://orcid.org/0000-0002-9700-4037","observed_orcids":["https://orcid.org/0000-0002-9700-4037"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathon Vallejo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9700-4037","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042696864","display_name":"Xiling Jiang","orcid":"https://orcid.org/0009-0007-9775-240X","observed_orcids":["https://orcid.org/0009-0007-9775-240X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiling Jiang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-9775-240X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069297078","display_name":"Marc Robert Theoret","orcid":"https://orcid.org/0000-0003-4973-5297","observed_orcids":["https://orcid.org/0000-0003-4973-5297"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marc R. Theoret","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4973-5297","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5019923674","display_name":"R. Angelo de Claro","orcid":"https://orcid.org/0000-0001-8362-1977","observed_orcids":["https://orcid.org/0000-0001-8362-1977"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Angelo de Claro","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8362-1977","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/blinatumomab","display_name":"blinatumomab","score":1.0},{"id":"https://openalex.org/keywords/b-cell-precursor-acute-lymphoblastic-leukemia","display_name":"B-cell precursor acute lymphoblastic leukemia","score":0.9909999966621399},{"id":"https://openalex.org/keywords/consolidation-chemotherapy","display_name":"consolidation chemotherapy","score":0.6819999814033508},{"id":"https://openalex.org/keywords/fda-approval","display_name":"FDA approval","score":0.6510000228881836}],"concepts":[{"id":"https://openalex.org/C2778020697","wikidata":"https://www.wikidata.org/wiki/Q410189","display_name":"Blinatumomab","level":4,"score":0.9261000156402588},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8870999813079834},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.6029000282287598},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5680999755859375},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5113999843597412},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4629000127315521},{"id":"https://openalex.org/C2780084366","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demographics","level":2,"score":0.45829999446868896},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.453900009393692},{"id":"https://openalex.org/C2776014549","wikidata":"https://www.wikidata.org/wiki/Q3050847","display_name":"Consolidation (business)","level":2,"score":0.44029998779296875},{"id":"https://openalex.org/C2781107101","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Acute lymphocytic leukemia","level":4,"score":0.37610000371932983},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.32519999146461487},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2791000008583069},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.2761000096797943},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2727000117301941},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.2578999996185303},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.25519999861717224}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.30363063","doi":"https://doi.org/10.1158/1078-0432.30363063","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30363063","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S3_from_FDA_Approval_Summary_Blinatumomab_for_the_Treatment_of_B-Cell_Precursor_Acute_Lymphoblastic_Leukemia_in_the_Consolidation_Phase_of_Multiphase_Chemotherapy/30363063/1/files/58751496.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30363063","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_S3_from_FDA_Approval_Summary_Blinatumomab_for_the_Treatment_of_B-Cell_Precursor_Acute_Lymphoblastic_Leukemia_in_the_Consolidation_Phase_of_Multiphase_Chemotherapy/30363063","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.30363063","doi":"https://doi.org/10.1158/1078-0432.30363063","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30363063","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S3_from_FDA_Approval_Summary_Blinatumomab_for_the_Treatment_of_B-Cell_Precursor_Acute_Lymphoblastic_Leukemia_in_the_Consolidation_Phase_of_Multiphase_Chemotherapy/30363063/1/files/58751496.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4415212160.pdf","grobid_xml":"https://content.openalex.org/works/W4415212160.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2952785646","https://openalex.org/W4413327167","https://openalex.org/W4415210646","https://openalex.org/W4413776394","https://openalex.org/W2884909078","https://openalex.org/W4283325151","https://openalex.org/W2527114621","https://openalex.org/W2965297464","https://openalex.org/W2946245700","https://openalex.org/W4413789096"],"abstract_inverted_index":{"Table":[0],"S3":[1],"shows":[2],"the":[3,6],"demographics":[4],"of":[5],"randomized":[7],"population":[8],"for":[9],"Study":[10],"20120215.":[11]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4415212160","counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2025-10-16T00:00:00"}
